Inhibitory Effects of Novel Hexapeptide on Melanogenesis by Regulating MITF in B16F10 Melanoma Cells
![]() |
Lee, Eung Ji
(Department of Chemistry and Cosmetics, Jeju National University)
Kim, Jandi (Department of Chemistry and Cosmetics, Jeju National University) Jeong, Min Kyeong (Department of Chemistry and Cosmetics, Jeju National University) Lee, Young Min (Department of Chemistry and Cosmetics, Jeju National University) Chung, Yong Ji (Department of Chemistry and Cosmetics, Jeju National University) Kim, Eun Mi (Department of Chemistry and Cosmetics, Jeju National University) |
1 | T. Hirobe, Keratinocytes regulate the function of melanocytes, Dermatologica Sinica, 32(4), 200 (2014). DOI |
2 | A. Hachiya, A. Kobayashi, A. Ohuchi, Y. Takema, and G. Imokawa, The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation, J. Invest. Dermatol., 116(4), 578 (2001). DOI |
3 | T. Hirobe, K. Hasegawa, R. Furuya, R. Fujiwara, and K. Sato, Effects of fibroblast-derived factors on the proliferation and differentiation of human melanocytes in culture, J. Dermatol. Sci, 71(1), 45 (2013). DOI |
4 | E. Schauer, F. Trautinger, A. Kock, A. Schwarz, R. Bhardwaj, M. Simon, J.C. Ansel, T. Schwarz, and T. A. Luger, Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes, J. Clin. Invest., 93(5), 2258 (1994). DOI |
5 | A. K. Chakraborty, Y. Funasaka, A. Slominski, G. Ermak, J. Hwang, J. M. Pawelek, and M. Ichihashi, Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B, Biochim. Biophys. Acta, 1313(2), 130 (1996). DOI |
6 | M. Khaled, L. Larribere, K. Bille, E. Aberdam, J. P. Ortonne, R. Ballotti, and C. Bertolotto, Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis, J. Biol. Chem., 277(37), 33690 (2002). DOI |
7 | K. Wakamatsu, A. Graham, D. Cook, and A. J. Thody, Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor, Pigment Cell Res., 10(5), 288 (1997). DOI |
8 | G. Imokawa, Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders, Pigment Cell Res., 17(2), 96 (2004). DOI |
9 | A. Chakraborty, A. Slominski, G. Ermak, J. Hwang, and J. Pawelek, Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for alpha MSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes, J. Invest. Dermatol., 105(5), 655 (1995). DOI |
10 | Y. M. Kim, S. E. Cho, and Y. K. Seo, The activation of melanogenesis by p-CREB and MITF signaling with extremely low-frequency electromagnetic fields on B16F10 melanoma, Life Sci., 162, 25 (2016). DOI |
11 | K. Kameyama, C. Sakai, S. Kuge, S. Nishiyama, Y. Tomita, S. Ito, K. Wakamatsu, and V. J. Hearing, The expression of tyrosinase, tyrosinase-related proteins 1 and 2 (TRP1 and TRP2), the silver protein, and a melanogenic inhibitor in human melanoma cells of differing melanogenic activities, Pigment Cell Res., 8(2), 97 (1995). DOI |
12 | G. Raposo, and M. S. Marks, Melanosomes-dark organelles enlighten endosomal membrane transport, Nat. Rev. Mol. Cell Biol., 8(10), 786 (2007). DOI |
13 | J. I. Park, H. Y. Lee, J. E. Lee, C. H. Myung, and J. S. Hwang, Inhibitory effect of 2-methyl-naphtho [1,2,3-de]quinolin-8-one on melanosome transport and skin pigmentation, Sci Rep, 6, 29189 (2016). DOI |
14 | L. D'Alba and M. D. Shawkey, Melanosomes: biogenesis, properties, and evolution of an ancient organelle, Physiol. Rev., 99(1), 1 (2019). DOI |
15 | M. Van Gele, B. Geusens, A. M. Schmitt, L. Aguilar, and J. Lambert, Knockdown of myosin Va isoforms by RNAi as a tool to block melanosome transport in primary human melanocytes, J. Invest. Dermatol., 128(10), 2474 (2008). DOI |
16 | N. Ohbayashi and M. Fukuda, Role of Rab family GTPases and their effectors in melanosomal logistics, J. Biochem., 151(4), 343 (2012). DOI |
17 | G. Cardinali, S. Ceccarelli, D. Kovacs, N. Aspite, L. V. Lotti, M. R. Torrisi, and M. Picardo, Keratinocyte growth factor promotes melanosome transfer to keratinocytes, J. Invest. Dermatol., 125(6), 1190 (2005). DOI |
18 | J. H. Epstein, Photocarcinogenesis, skin cancer, and aging, J. Am. Acad. Dermatol., 9(4), 4 87 ( 1983 ). DOI |
19 | R. Speeckaert, M. Van Gele, M. M. Speeckaert, J. Lambert, and N. van Geel, The biology of hyperpigmentation syndromes, Pigment Cell Melanoma Res, 27(4), 512 (2014). DOI |
20 | M. B. C. Maymone, H. H. Neamah, E. A. Secemsky, and N. A. Vashi, Correlating the dermatology life quality index and skin discoloration impact evaluation questionnaire tools in disorders of hyperpigmentation, J. Dermatol., 45(3), 361 (2018). DOI |
21 | T. Pillaiyar, M. Manickam, and V. Namasivayam, Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors, J Enzyme Inhib Med Chem, 32(1), 403 (2017). DOI |
22 | M. L. W. Juhasz and M. K. Levin, The role of systemic treatments for skin lightening, J Cosmet Dermatol, 17(6), 1144 (2018). DOI |
23 | L. Zhang and T. J. Falla, Cosmeceuticals and peptides, Clin. Dermatol., 27(5), 485 (2009). DOI |
24 | B. Reddy, T. Jow, and B. M. Hantash, Bioactive oligopeptides in dermatology: Part I, Exp. Dermatol., 21(8), 563 (2012). DOI |
25 | B. Reddy, T. Jow, and B. M. Hantash, Bioactive oligopeptides in dermatology: Part II, Exp. Dermatol., 21(8), 569 (2012). DOI |
26 | A. A. Strömstedt, M. Pasupuleti, A. Schmidtchen, and M. Malmsten, Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37, Antimicrob. Agents Chemother., 53(2), 593 (2009). DOI |
27 | V. V. Pai, P. Bhandari, and P. Shukla, Topical peptides as cosmeceuticals, Indian J Dermatol Venereol Leprol, 83(1), 9 (2017). DOI |
28 | S. Marepally, C. H. Boakye, P. P. Shah, J.R . Etukala, A. Vemuri, and M. Singh, Design, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug delivery, PLoS ONE, 8(12), e82581 (2013). DOI |
29 | H. Kalluri, and A. K. Banga, Transdermal delivery of proteins, AAPS PharmSciTech, 12(1), 431 (2011). DOI |
![]() |